Submit an abstract before 15 February, 2018  Submit your abstract now!

Abstract submission

We are now accepting abstract submissions for the ERS International Congress 2018. Submit an abstract.

For questions regarding abstract subsmission and abstract sessions, please contact:

Call for abstracts

From December 2017, abstracts may be submitted online for the ERS International Congress 2018. The abstract submission deadline is 15 February, 2018. 

Paper submissions will not be accepted.

The Congress Programme Committee will allocate successful abstracts to session formats, including:

  • Oral Presentations
  • Poster Discussions
  • Thematic Poster sessions

Abstract authors will be notified of the status of their abstract by May 2018; session formats and scheduling of presentations will be communicated by the end of June 2018.

Accepted and presented during the ERS Congress abstracts will be published in a supplement of the online version of the European Respiratory Journal known as the Abstract Book. Publication in the Abstract Book or Congress Guide requires registration by at least one author.

Correspondence and further information regarding abstract travel grants and sponsorship will be sent to the corresponding author only. If you intend to apply for ERS sponsorship once abstracts have been accepted, please ensure that you are the corresponding author of the abstract.

Online submission

Online submission via myERS enables you to create an account and save your abstract. If you already have a myERS account, you will be able to submit your abstract directly.

Once you have saved your abstract, you can later edit or update it until you feel it is ready for submission.

All abstracts must be submitted by the deadline of 15 February, 2018 via myERS.

Late-breaking abstracts

From May 2018, late-breaking abstracts may be submitted online for the ERS International Congress 2018. The abstract submission deadline will be 31 May, 2018.

Late-breaking abstracts must contain novel data that has not been presented elsewhere. Additional information (including submission fees) will be available on the ERS Congress website in due course.


Frequently asked questions on abstracts


What is an abstract?

An abstract is a summary of a paper (research publication). The study and results reported should be novel and not simply an extension of previously published work.

What is a late-breaking abstract?

Abstracts that are considered as late-breaking must contain novel data and this data must became available for public dissemination only after the standard abstract deadline on 15 February 2018.

The study and results reported should be novel and not simply an extension of previously published work. The late-breaking abstract round is not designed to favour investigators who unintentionally missed the deadline for the regular abstract submission.

My project is still ongoing and there are no results yet, should I still submit an abstract?

Abstracts are intended to present scientific studies and research. If your study is currently ongoing and you only have preliminary data, but it seems relevant or significant, you can submit the abstract. However please be aware that abstracts with incomplete data may have less chance of being accepted for the ERS International Congress.

After your abstract is accepted you cannot update the content of your abstract for the official publication as the accepted version will be published, however you are permitted to present updated information onsite at the Congress.

Can I submit an abstract that has already been presented at different event?

We do not accept abstracts that have already been presented and published. You are permitted to submit something similar at the ERS Congress, however we expect additions / new data to an abstract presented at another congress.

Can I submit a case report study?

We do not encourage to submit the case study abstracts however we accept them if they are well prepared. We do not provide specific templates for this kind of abstracts.

Do I need to disclose information of conflict of interest in my abstract?

Yes; when you are submitting your abstract you will have the opportunity to disclose your conflict of interest. Conflict of interest statement is only required for the first author.

Where can I find the guidelines on how to prepare an abstract?

You can access the instructions from this page or from the submission platform.

What is the required structure for an abstract?

Title: The title should be an accurate description of the abstract's contents. It should explain as much as possible about the context and the aims of the study. The title should be about 10–12 words long, and should include the scope of the investigation, the study design and the goal. The title should be a description of what was investigated rather than a statement of the results or conclusions. The abstract title should be easy for the reader to understand and should not include jargon or unfamiliar acronyms or abbreviations. The title should not be in capital letters.

Authors: The list of authors should be restricted to those individuals who carried out the study, conceived it, designed it, gathered the data, analysed the numbers and wrote the abstract. The author who will present the abstract should be listed first. Every listed author should read and approve the abstract before it is submitted.

Main text: A good abstract should address the five following questions in the relevant sections:

1. "Why did you start?" – Introduction or background / You should summarise, preferably in one sentence, the current knowledge specifically in relation to the work you are presenting.

2. "What did you try to do?" – Aims and objectives / State the aim of your study, and ideally include a short statement of the study's hypothesis. A legitimate scientific study is not done "to prove that something is true" but rather "to find out whether it is true." The distinction may seem small but it makes a significant difference. A formal hypothesis shows that you are objective.

3. "What did you do?" – Methods / In an abstract, the description of the methods has to be concise, and much of the details of what was done must be omitted. However, in a few short sentences, you can give the reader a good idea of the design of the study, the context in which it was done, and the types of patients or measurements that were included.

4. "What did you find?" – Results / It is important to give the main results of the study, not in subjective terms ("We found device X to be superior to device Y") but also in the form of some real data. You will need to choose which findings to report here: it should be the most important data in your study, and the findings on which your conclusions will be based. Do not include a table or figure unless you need it to show your results.

5. "What does it mean?" – Conclusions / Here, space constraints generally limit you to a single sentence of why you think your findings are important, and their potential implications. Keep your conclusions reasonable and supportable by the findings of your study. Remember that if your study was restricted to certain patients, or a particular therapy, or a specific device, its results may not extend beyond these restrictions.

Please see the full guidelines for more information

Further help needed

If none of the answers above could help you, you can contact the ERS office. We will do our best to answer your queries within a maximum of 5 working days. Thank you for your patience and understanding.